Gilead Sciences (NASDAQ:GILD) Issues FY 2024 Earnings Guidance
Gilead Sciences (NASDAQ:GILD – Get Free Report) updated its FY 2024 earnings guidance on Tuesday. The company provided EPS guidance of 6.850-7.250 for the period, compared to the consensus EPS estimate of 7.210. The company issued revenue guidance of $27.1 billion-$27.5 billion, compared to the consensus revenue estimate of $27.7 billion. Gilead Sciences also updated […]